Search results
Colorado Republicans celebrate policy wins in state legislative session
Colorado Springs Gazette· 2 days agoHouse and Senate Republicans celebrated more big policy wins during the 2024 legislative session....
Earnings call: Aquestive Therapeutics highlights progress and outlook for 2024
Investing.com· 2 days agoAquestive Therapeutics ( NASDAQ : NASDAQ: AQST ) has shared an optimistic update during its...
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
WKRN Nashville· 1 day agoSN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer ...
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
Benzinga· 1 day agoSN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 SN, a new drug for polymer nanoparticle ...
Earnings call: Aquestive Therapeutics highlights progress and outlook for 2024 By Investing.com
Investing.com· 2 days agoAquestive Therapeutics (NASDAQ: NASDAQ:AQST) has shared an optimistic update during its...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 day agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
WFRV 5 Green Bay· 2 days agoIn the fight against cancer, a political stumbling block was recently put in place by the US Congress after it voted against the renewal of funding for President Biden's "Cancer Moon Shot" designed ...
Biotech CEL-SCI gets FDA go-ahead to conduct investigational cancer immunotherapy study - Maryland...
The Daily Record· 3 days agoThe project will study the drug’s effectiveness in newly diagnosed advanced primary head and neck cancer patients with no lymph node involvement, determined via PET scan, and with low PD-L1 ...
Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
Quad-City Times· 3 days agoRyan Confer Appointed Genprex President and CEO and to its Board of Directors
Citius Pharmaceuticals to Participate in Upcoming EF Hutton and H.C. Wainwright Investor Conferences
FOX 4 Kansas City· 1 day agoCitius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical ...